vanicoside A: isolated from Polygonum pensylvanicum; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Polygonum | genus | A plant genus of the family POLYGONACEAE that is an ingredient of Shou-Wu-Pian, a Chinese herbal preparation (DRUGS, CHINESE HERBAL). The common name of black bindweed also refers to TAMUS or Fallopia (use POLYGONACEAE).[MeSH] | Polygonaceae | The only family of the buckwheat order (Polygonales) of dicotyledonous flowering plants. It has 40 genera of herbs, shrubs, and trees.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 6449878 |
MeSH ID | M0230776 |
Synonym |
---|
alpha-d-glucopyranoside, 1,3,6-tris-o-((2e)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-beta-d-fructofuranosyl, 2-acetate 6-((2e)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate) |
alpha-d-glucopyranoside, 1,3,6-tris-o-(3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-beta-d-fructofuranosyl, 2-acetate 6-(3-(4-hydroxy-3-methoxyphenyl)-2-propenoate), (1(1(e),3(e),6(e)),6(e))- |
155179-22-9 |
vanicoside a |
[(2r,3r,4s,5r)-5-[(2r,3r,4s,5s,6r)-3-acetyloxy-4,5-dihydroxy-6-[[(e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-3-hydroxy-4-[(e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-5-[[(e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxolan-2-yl]methy |
Excerpt | Reference | Relevance |
---|---|---|
"Vanicoside A also has an acetyl group in the sucrose moiety." | ( Antimicrobial substances from rhizomes of the giant knotweed Polygonum sachalinense against the fish pathogen Photobacterium damselae subsp. piscicida. Inoue, N; Kawai, Y; Kumagai, H; Kurihara, H; Sawano, R; Yamazaki, K, ) | 0.85 |
"Vanicoside A also has an acetyl group in the sucrose moiety." | ( Antimicrobial substances from rhizomes of the giant knotweed Polygonum sachalinense against the fish pathogen Photobacterium damselae subsp. piscicida. Inoue, N; Kawai, Y; Kumagai, H; Kurihara, H; Sawano, R; Yamazaki, K, ) | 0.85 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.78) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |